Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea
- 1 February 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in European Journal Of Cancer Prevention
- Vol. 18 (1), 56-61
- https://doi.org/10.1097/cej.0b013e328305a0a6
Abstract
Cervical cancer screening with the conventional Papanicolaou test is recommended for the women aged 30 years and more in Korea. Cervical infection with human papillomavirus (HPV) is the most important cause of cervical cancer and Chlamydia trachomatis (CT) is the most common bacterial sexually transmitted infection and may also be associated with risk of cervical cancer. A cross-sectional study of women attending the National Cervical Cancer Screening Program in Busan and Suwon was carried out. Exfoliated cervical cells were collected, and questionnaires were administered to 4595 women. High-risk HPV types and CT were tested by Hybrid Capture 2 (HC2). HPV genotyping of 355 high-risk HPV-positive women at HC2 was performed using linear array. Age-standardized prevalence of high-risk HPV types and CT was 10.4% (95% confidence interval: 9.5–11.3) and 4.3% (95% confidence interval: 3.7–4.8). That 68.5% of women were high-risk HPV-positive at HC2 was confirmed by Linear Array whereas 17.5% seemed to be infected with only low-risk HPV types, not normally detected by HC2. Korean women showed a relatively high prevalence of high-risk HPV and a rather low prevalence of CT. As in cancer-free women in other Asian populations, HPV 52, 58, and 39 were detected more frequently than HPV 16. Cross-reaction of HC2 with low-risk HPV types is of some concern, were the test to be used in primary screening.Keywords
This publication has 29 references indexed in Scilit:
- Cervical Infection With Chlamydia trachomatis and Neisseria gonorrhoeae in Women From Ten Areas in Four ContinentsSexually Transmitted Diseases, 2007
- Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear ResultsJournal of Clinical Microbiology, 2007
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisThe Lancet Infectious Diseases, 2007
- National Cancer Incidence for the Year 2002 in KoreaCancer Research and Treatment, 2007
- Chlamydia trachomatis infection and persistence of human papillomavirusInternational Journal of Cancer, 2005
- The cost-effectiveness of human papillomavirus screening for cervical cancerThe European Journal of Health Economics, 2005
- Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence DatabaseCancer Research and Treatment, 2005
- Prevalence of human papillomavirus infection in women in Busan, South KoreaInternational Journal of Cancer, 2002
- A population‐based prospective study of Chlamydia trachomatis infection and cervical carcinomaInternational Journal of Cancer, 2002
- Evidence forChlamydia trachomatisas a Human Papillomavirus Cofactor in the Etiology of Invasive Cervical Cancer in Brazil and the PhilippinesThe Journal of Infectious Diseases, 2002